Cited in:


This article has been cited by:

  1. 1
    Li-Ching Huang, Miin-Jye Wen, Siu Hung Cheung, Non-Inferiority Studies with Multiple New Treatments and Heterogeneous Variances, Journal of Biopharmaceutical Statistics, 2014, 141217111901005


  2. 2
    Karola Kombrink, Axel Munk, Tim Friede, Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data, Statistics in Medicine, 2013, 32, 18
  3. 3
    Patrick Schlömer, Werner Brannath, Group sequential designs for three-arm ‘gold standard’ non-inferiority trials with fixed margin, Statistics in Medicine, 2013, 32, 28
  4. 4
    Eisuke Hida, Toshiro Tango, Three-Arm Noninferiority Trials with a Prespecified Margin for Inference of the Difference in the Proportions of Binary Endpoints, Journal of Biopharmaceutical Statistics, 2013, 23, 4, 774


  5. 5
    Kathrin Stucke, Meinhard Kieser, A general approach for sample size calculation for the three-arm ‘gold standard’ non-inferiority design, Statistics in Medicine, 2012, 31, 28
  6. 6
    Koon Shing Kwong, Siu Hung Cheung, Anthony J. Hayter, Miin-Jye Wen, Extension of three-arm non-inferiority studies to trials with multiple new treatments, Statistics in Medicine, 2012, 31, 24
  7. 7
    Joachim Röhmel, Iris Pigeot, Statistical strategies for the analysis of clinical trials with an experimental treatment, an active control and placebo, and a prespecified fixed non-inferiority margin for the difference in means, Statistics in Medicine, 2011, 30, 26